Compounds > framycetin
Page last updated: 2024-08-18

framycetin and zidovudine

framycetin has been researched along with zidovudine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, FF; Hammarskjold, ML; Ptak, R; Raman, S; Rekosh, D; Shuck-Lee, D; Willard, R1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Campillo, NE; Guerra, A; Páez, JA1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Bayard, F; Delarue, F; Faye, JC; Mesange, F; Puel, J1
Davis, K; Fabian, E; Greenhaw, J; Groeters, S; Herold, M; Kamp, H; Looser, R; Marxfeld, H; Mattes, W; Mellert, W; Moeller, N; Montoya-Parra, G; Prokoudine, A; Strauss, V; van Ravenzwaay, B; Walk, T1

Other Studies

7 other study(ies) available for framycetin and zidovudine

ArticleYear
Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Animals; Anti-HIV Agents; Cell Line; Chlorocebus aethiops; COS Cells; Gene Products, rev; Genes, env; Heterocyclic Compounds; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Virus Replication

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
    Molecular pharmacology, 1996, Volume: 50, Issue:1

    Topics: Antiviral Agents; Binding Sites; Cells, Cultured; Estrogen Antagonists; Ethanol; HIV Core Protein p24; HIV-1; Humans; Interleukin-2; Kinetics; Ligands; Lymphocyte Activation; Lymphocytes; Neomycin; Receptors, Drug; Tamoxifen; Virion; Virus Replication; Zidovudine

1996
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
    Toxicology letters, 2014, Nov-04, Volume: 230, Issue:3

    Topics: Animals; Atropine; Captopril; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Female; Flutamide; Lamivudine; Liver; Male; Mannitol; Metabolomics; Methotrexate; Neomycin; Oxidative Stress; Phenytoin; Piperazines; Propylthiouracil; Rats; Rats, Wistar; Streptomycin; Triazoles; Valproic Acid; Vancomycin; Zidovudine

2014